- Home
- EHC
EHC
Encompass Health Corporation
as 04-01-2025 4:00pm EST
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | BIRMINGHAM |
| Market Cap: | N/A | IPO Year: | 1986 |
| Target Price: | $107.38 | AVG Volume (30 days): | 695.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 4.46 | EPS Growth: | 28.32 |
| 52 Week Low/High: | $78.53 - $104.55 | Next Earning Date: | 04-23-2025 |
| Revenue: | $5,373,200,000 | Revenue Growth: | 11.91% |
| Revenue Growth (this year): | 10.1% | Revenue Growth (next year): | 8.67% |
Stock Insider Trading Activity of Encompass Health Corporation (EHC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Price Andrew L | EHC | Chief Accounting Officer | Feb 13 '25 | Sell | $98.29 | 5,042 | $495,578.18 | 69,164 |
Latest Encompass Health Corporation News
EHC Breaking Stock News: Dive into EHC Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Here's Why Encompass Health (EHC) is a Strong Value Stock
StockStory
5 days ago
2 Reasons EHC is Risky and 1 Stock to Buy Instead
Zacks
7 days ago
Here's Why Encompass Health (EHC) is a Strong Momentum Stock
Simply Wall St.
11 days ago
Encompass Health Corporation's (NYSE:EHC) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Zacks
13 days ago
Encompass Health Expands Partnership With Piedmont in Georgia
Zacks
13 days ago
Here's Why Encompass Health (EHC) is a Strong Growth Stock
Hospital Management
14 days ago
Encompass Health and Piedmont open new Athens rehabilitation hospital
PR Newswire
14 days ago
Rehabilitation Hospital of Athens Now Open in Georgia
Compare EHC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EHC Encompass Health Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.